Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Mater Today (Kidlington). 2022 Feb 23;56:79–95. doi: 10.1016/j.mattod.2022.01.025

Fig 5.

Fig 5.

Supernatants of cultures treated with GNP inhibit CC proliferation, migration, invasion and EMT. CM preparation: 5x105 CP20-EGFP or OV90-EGFP cells were seeded to 10 cm dishes with or without HMEC and TAF18 of equal numbers. Cells were starved from the next day for 16 h and then treated with 25 μg/ml GNP or PBS in fresh serum-free media for 2 days. Supernatants were collected and centrifuged to remove cell debris and GNP. (A) Proliferation: CP20-EGFP or OV90-EGFP cells were seeded at 1000 cells/well to 96-well plates. The following day the CM were added to plates and incubated for 3 days. EGFP fluorescence intensity was measured after treatment. Experiments were performed in sextuplicate and repeated 3 times. (B) Migration: OV90-EGFP (designated as OV90 hereafter) cells (8x104 cells) were seeded to each transwell. Migration was induced by CM added to the outwells for 16 h. Experiments were performed in duplicate and repeated 3 times. (C) Invasion: OV90 cells (1x105 cells) were seeded to each Matrigel precoated transwell. Invasion was induced by CM added to the outwells for 24 h. Experiments were performed in duplicate and repeated 3 times. (D) EMT marker expression change upon CM treatment. OV90 cells were treated for 2 days with CM from OV90 alone or from the OV90, TAF18 and HMEC cocultures (MIX) incubated with or without GNP. Proteins (5 μg- 50 μg) in cell lysates were separated with 6% or 12% SDS-PAGE. GAPDH was used as loading control. Experiments were repeated 3 times. *, p<0.05, compared to corresponding control. #, p<0.05, compared to CP20 CON or OV90 CON.